Nasus Pharma NSRX
NYSE NSRX
$3.40 +0.16 (+4.65%)
As of: Oct 21, 2026 · 11:35 AM EDT

Nasus Pharma (NSRX) Total Debt (2024 - 2025)

Updated

Nasus Pharma (NSRX) posted Total Debt of $2.56 million for Q2 2025.

Analysis

Nasus Pharma (NSRX) Total Debt (2024 - 2025) Analysis & Trends

At the end of FY2024, Nasus Pharma's Total Debt came in at $1.8 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 49.04 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 70.82 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 32.35 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 26.25 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 63.19 Bn
10 Nasus Pharma 27.23 Mn 10.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 2.56 Mn
Dec 31, 2024 1.80 Mn
API Access

Nasus Pharma Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=NSRX&period=max&api_key=YOUR_API_KEY